Trial Profile
Utilisation and Safety of Deferasirox (Exjade): an Observational Cohort Study in England
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Oct 2017
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Iron overload; Myelodysplastic syndromes; Thalassaemia
- Focus Adverse reactions
- 10 Oct 2017 Results published in the Drug Safety
- 30 Aug 2017 Results evaluating safety and utilization of Deferasirox in older adults, presented at the 33rd International Conference on Pharmacoepidemiology and Therapeutic Risk Management
- 06 Oct 2015 New trial record